The city of College Station, Texas, currently has 2 active clinical trials seeking participants for Atopic Dermatitis research studies.
Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis
Recruiting
This Phase 2a trial will evaluate the effects of EP262 in subjects with atopic dermatitis
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
01/29/2024
Locations: J&S Studies, Inc., College Station, Texas
Conditions: Atopic Dermatitis
Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis
Recruiting
The purpose of this study is to evaluate the safety and tolerability of XmAb27564 following multiple doses among participants with plaque psoriasis and atopic dermatitis.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
08/22/2023
Locations: J&S Studies, Inc, College Station, Texas
Conditions: Psoriasis, Atopic Dermatitis